These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

78 related items for PubMed ID: 17629032

  • 1. Evaluation of molecular markers in hepatic metastasis of colorectal adenocarcinoma.
    Murad JC, Ribeiro U, Safatle-Ribeiro AV, Parra E, Rawet V, Corbett CE, Ferreira VA, Pugliese V, Saad WA, Habr-Gama A, Gama-Rodrigues J.
    Hepatogastroenterology; 2007 Jun; 54(76):1029-33. PubMed ID: 17629032
    [Abstract] [Full Text] [Related]

  • 2. p53, DCC and thymidylate synthase as predictors of survival after resection of hepatic metastases from colorectal cancer.
    Saw RP, Koorey D, Painter D, Gallagher PJ, Solomon MJ.
    Br J Surg; 2002 Nov; 89(11):1409-15. PubMed ID: 12390383
    [Abstract] [Full Text] [Related]

  • 3. Venous invasion and down-regulation of p21(WAF1/CIP1) are associated with metastasis in colorectal carcinomas.
    Mitomi H, Mori A, Kanazawa H, Nishiyama Y, Ihara A, Otani Y, Sada M, Kobayashi K, Igarashi M.
    Hepatogastroenterology; 2005 Nov; 52(65):1421-6. PubMed ID: 16201087
    [Abstract] [Full Text] [Related]

  • 4. Clinicopathological analysis of colorectal cancer liver metastasis and intrahepatic cholangiocarcinoma: are they just apples and oranges?
    Chiu CT, Chiang JM, Yeh TS, Tseng JH, Chen TC, Jan YY, Chen MF.
    Dig Liver Dis; 2008 Sep; 40(9):749-54. PubMed ID: 18329969
    [Abstract] [Full Text] [Related]

  • 5. Predictive molecular markers for colorectal cancer patients with resected liver metastasis and adjuvant chemotherapy.
    Lassmann S, Tang L, Capanu M, Brabletz T, Schöpflin A, Zur Hausen A, Gonen M, Kemeny N, Shia J, Klimstra D, Werner M.
    Gastroenterology; 2007 Dec; 133(6):1831-9. PubMed ID: 18054556
    [Abstract] [Full Text] [Related]

  • 6. Expression of P53, P27 and KI-67 in colorectal cancer patients of various ethnic origins: clinical and tissue microarray based analysis.
    Cohen T, Prus D, Shia J, Abu-Wasel B, Pinto MG, Freund HR, Stojadinovic A, Grakov A, Peretz T, Nissan A.
    J Surg Oncol; 2008 Apr 01; 97(5):416-22. PubMed ID: 18286523
    [Abstract] [Full Text] [Related]

  • 7. Micropapillary component in colorectal carcinoma is associated with lymph node metastasis in T1 and T2 Stages and decreased survival time in TNM stages I and II.
    Xu F, Xu J, Lou Z, Di M, Wang F, Hu H, Lai M.
    Am J Surg Pathol; 2009 Sep 01; 33(9):1287-92. PubMed ID: 19471152
    [Abstract] [Full Text] [Related]

  • 8. Outcomes after resection of synchronous or metachronous hepatic and pulmonary colorectal metastases.
    Miller G, Biernacki P, Kemeny NE, Gonen M, Downey R, Jarnagin WR, D'Angelica M, Fong Y, Blumgart LH, DeMatteo RP.
    J Am Coll Surg; 2007 Aug 01; 205(2):231-8. PubMed ID: 17660069
    [Abstract] [Full Text] [Related]

  • 9. Comparative analysis of thymidylate synthase at the protein, mRNA, and DNA levels as prognostic markers in colorectal adenocarcinoma.
    Ren DN, Kim IY, Koh SB, Chang SJ, Eom M, Yi SY, Seong SH, Kim MD, Bronner MP, Cho MY.
    J Surg Oncol; 2009 Dec 01; 100(7):546-52. PubMed ID: 19722231
    [Abstract] [Full Text] [Related]

  • 10. Comparative analysis of prognostic significance of molecular markers of apoptosis with clinical stage and tumor differentiation in patients with colorectal cancer: a single institute experience.
    Ivanov K, Kolev N, Tonev A, Nikolova G, Krasnaliev I, Softova E, Tonchev A.
    Hepatogastroenterology; 2009 Dec 01; 56(89):94-8. PubMed ID: 19453036
    [Abstract] [Full Text] [Related]

  • 11. Prognostic value of ERCC1, thymidylate synthase, and glutathione S-transferase pi for 5-FU/oxaliplatin chemotherapy in advanced colorectal cancer.
    Kim SH, Kwon HC, Oh SY, Lee DM, Lee S, Lee JH, Roh MS, Kim DC, Park KJ, Choi HJ, Kim HJ.
    Am J Clin Oncol; 2009 Feb 01; 32(1):38-43. PubMed ID: 19194123
    [Abstract] [Full Text] [Related]

  • 12. Correlations between clinicopathological parameters and molecular signatures of primary tumors for patients with stage T3n0 colorectal adenocarcinomas: a single center retrospective study on 100 cases.
    András C, Tóth L, Molnár C, Tanyi M, Csiki Z, Dezso B, Pósán J, Shemirani AH, Csiki E, Szántó J.
    Hepatogastroenterology; 2012 Jun 01; 59(116):1091-7. PubMed ID: 22414548
    [Abstract] [Full Text] [Related]

  • 13. Is resection of periampullary or pancreatic adenocarcinoma with synchronous hepatic metastasis justified?
    Gleisner AL, Assumpcao L, Cameron JL, Wolfgang CL, Choti MA, Herman JM, Schulick RD, Pawlik TM.
    Cancer; 2007 Dec 01; 110(11):2484-92. PubMed ID: 17941009
    [Abstract] [Full Text] [Related]

  • 14. Bio-pathological factors of prognostic value in colorectal adenocarcinomas.
    Mottolese M, Buglioli S, Piperno G, Sperduti I, Giannarelli D, D'Angelo C, Cosimelli M.
    J Exp Clin Cancer Res; 2003 Dec 01; 22(4 Suppl):163-6. PubMed ID: 16767924
    [Abstract] [Full Text] [Related]

  • 15. Correlations of proliferation markers, p53 expression and histological findings in colorectal carcinoma.
    Georgescu CV, Săftoiu A, Georgescu CC, Ciurea R, Ciurea T.
    J Gastrointestin Liver Dis; 2007 Jun 01; 16(2):133-9. PubMed ID: 17592558
    [Abstract] [Full Text] [Related]

  • 16. Identification of immunohistochemical prognostic markers for survival after resection of pulmonary metastases from colorectal carcinoma.
    Pfannschmidt J, Bade S, Hoheisel J, Muley T, Dienemann H, Herpel E.
    Thorac Cardiovasc Surg; 2009 Oct 01; 57(7):403-8. PubMed ID: 19795327
    [Abstract] [Full Text] [Related]

  • 17. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
    Ioachim E.
    Int J Clin Pract; 2008 Nov 01; 62(11):1736-43. PubMed ID: 19143860
    [Abstract] [Full Text] [Related]

  • 18. The clinical importance of Ki-67, p16, p14, and p57 expression in patients with advanced ovarian carcinoma.
    Khouja MH, Baekelandt M, Nesland JM, Holm R.
    Int J Gynecol Pathol; 2007 Oct 01; 26(4):418-25. PubMed ID: 17885492
    [Abstract] [Full Text] [Related]

  • 19. The validity of clinical risk score for patients undergoing liver resection for colorectal metastases.
    Ivanecz A, Potrc S, Horvat M, Jagric T, Gadzijev E.
    Hepatogastroenterology; 2009 Oct 01; 56(94-95):1452-8. PubMed ID: 19950809
    [Abstract] [Full Text] [Related]

  • 20. Surgical technique and systemic inflammation influences long-term disease-free survival following hepatic resection for colorectal metastasis.
    Gomez D, Morris-Stiff G, Wyatt J, Toogood GJ, Lodge JP, Prasad KR.
    J Surg Oncol; 2008 Oct 01; 98(5):371-6. PubMed ID: 18646038
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.